JP Patent

JP6617097B2 — 抗生物質を用いて過体重および肥満の患者における感染を治療するための組成物

Assigned to メリンタ サブシディアリー コーポレーション · Expires 2019-12-04 · 6y expired

What this patent protects

Patent listed against delafloxacin-meglumine.

Drugs covered by this patent

Patent Metadata

Patent number
JP6617097B2
Jurisdiction
JP
Classification
—
Expires
2019-12-04
Drug substance claim
No
Drug product claim
No
Assignee
メリンタ サブシディアリー コーポレーション
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.